Company Profile
Updated: 17-DEC-09ZIOPHARM Oncology Inc.
Public Company, Headquarters Location
1180 Ave. of the Americas, Ste. 1920, New York, NY 10036-8401, United States
(646)214-0700, (646)214-0711 fax, http://www.ziopharm.com
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Development of cancer drugs.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Research and Markets: Multiple Myeloma Therapeutics - US Market Trends & Analysis.
Business Wire; 12/17/2009; 603 words; ...Company (USA) * Kosan Biosciences, Inc. (USA) * Celgene Corporation...Ltd Switzerland) * Genentech, Inc. (USA) * Genta Incorporated...USA) * Seattle Genetics (USA) * Ziopharm Oncology, Inc. (USA) * 6. MARKET ANALYTICS...
ZIOPHARM ONCOLOGY REPORTS ACQUISITION BY DIRECTOR CANNON (New York)
US Fed News Service, Including US State News; 12/15/2009; 295 words; WASHINGTON, Dec. 15 -- ZIOPHARM Oncology Inc. (ZIOP), New York, has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial interest...
ZIOPHARM Announces Commencement of Public Offering.
Cancer Weekly; 12/15/2009; 587 words; ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced that...managers for the offering (see also ZIOPHARM Oncology, Inc.). The Company plans to use...Professional Services, Stock Market, ZIOPHARM Oncology Inc. This article was prepared by...
ZIOPHARM Prices Public Offering.
Cancer Weekly; 12/15/2009; 723 words; ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the...managers for the offering (see also ZIOPHARM Oncology, Inc.). The offering will result...Investment, Oncology, Stock Market, ZIOPHARM Oncology Inc. This article was prepared by...
ZIOPHARM ONCOLOGY REPORTS DISPOSITION BY CEO LEWIS (New York)
US Fed News Service, Including US State News; 12/8/2009; 299 words; WASHINGTON, Dec. 8 -- Ziopharm Oncology Inc. (ZIOP), New York, has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial interest...
Recent News Articles
- TIMOTHY MCINERNEY of ZIOPHARM Oncology Inc (NasdaqCM: ZIOP) bought Shares of ZIOP.
M2 Presswire - December 14, 2009 - Ziopharm Posts 3Q Financial Results and Updates Clinical Progress.(Ziopharm Oncology Inc.)(Financial report)
Wireless News - November 16, 2009 - CEO INTERVIEW: ZIOPHARM Oncology, Inc. - Dr. Jonathan Lewis.
Wall Street Transcript Digest - October 19, 2009 - ZIOPHARM Oncology Inc-Financial Company Report.
M2 Presswire - March 11, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning